Congratulations to Engle Lab graduate student Yilin Cao, who has been selected as one of 22 members of the 2026 ACS Future Pharma Innovators cohort!
The program recognizes graduate students with strong scientific excellence and a passion for careers in pharma, pairing them with an industry mentor and supporting travel to present at the ACS Fall 2026 meeting in Chicago. Yilin will present her recently published work on Pd(II)-catalyzed cyclopropanation of unactivated alkenes using alkyl sulfonyl fluorides, published in Nature Synthesis. Congratulations, Yilin β well deserved!
π° ACS Future Pharma Innovators: https://acsprof.org/awards/acs-future-pharma-innovators/
π Nature Synthesis paper: https://www.nature.com/articles/s44160-025-00925-1
Molecular Complexity through Catalysis 